Skip to content
Medicine information

Rybelsus

A tablet form of semaglutide, a GLP-1 receptor agonist, taken once a day and authorised in the EU for type 2 diabetes.

General information, not medical advice. Docalo does not sell medicines, and prescription-only medicines are prescribed only after an individual medical assessment.

Medicine information

What Rybelsus is and how it works

Rybelsus contains semaglutide, a copy of the gut hormone GLP-1, in a tablet built to be absorbed through the stomach wall. It helps the body release insulin after meals and lowers blood sugar.

Its EU authorisation covers type 2 diabetes only. Food, drink and other tablets in the stomach reduce how much is absorbed, which is why the instructions on how to take it are strict.

Who it may suit, according to the label

  • Adults with type 2 diabetes that is not sufficiently controlled, alongside diet and exercise.
  • On its own when metformin is not suitable, or added to other diabetes medicines.
  • It is not authorised for weight management or for type 1 diabetes.

Only a doctor who knows your history can decide whether a medicine suits you.

How to use Rybelsus

On an empty stomach. Swallow the tablet whole with a sip of water, up to half a glass (120 ml), on an empty stomach.

Wait 30 minutes. Wait at least 30 minutes before eating, drinking or taking other tablets. Waiting less reduces how much semaglutide is absorbed.

Built up in steps. The EU product information covers two tablet series whose strengths are not interchangeable mg for mg. The newer series starts at 1.5 mg once a day for one month, then 4 mg; the original series starts at 3 mg, then 7 mg. After at least one month on a dose, the prescriber may step up to 9 mg (14 mg in the original series), then 25 mg and 50 mg. 50 mg once a day, as a single tablet, is the maximum.

Common side effects

Get urgent medical help if (whatever the frequency): Severe, persistent stomach pain, often spreading to the back, Swelling of the face, lips, tongue or throat, or trouble breathing

Very common (may affect more than 1 in 10 people): nausea, diarrhoea, low blood sugar when used with insulin or a sulfonylurea

Common (may affect up to 1 in 10 people): vomiting, stomach pain, constipation, indigestion, reduced appetite, tiredness, low blood sugar when used with other diabetes tablets, headache, dizziness, altered skin sensation such as tingling or burning, reported mainly at 25 mg and 50 mg

Safety

Do not use Rybelsus if

  • You have ever had an allergic reaction to semaglutide or any ingredient in the tablet
  • You have type 1 diabetes or diabetic ketoacidosis, because semaglutide is not a substitute for insulin
  • You are pregnant, planning a pregnancy within the next two months, or breastfeeding

People with diabetic eye disease need closer eye checks when blood sugar falls quickly. Always read the patient leaflet supplied with the tablets.

FAQs

Your questions answered

Rybelsus3 questions
Is Rybelsus the same as Ozempic?
Both contain semaglutide and both are authorised in the EU for type 2 diabetes, but Rybelsus is a daily tablet and Ozempic a weekly injection. The doses are not equivalent, so one cannot be swapped for the other without a prescriber setting a new dose.
Food, drink and other tablets in the stomach reduce how much semaglutide is absorbed. Taking it with a little water and waiting at least 30 minutes keeps absorption steady from day to day.
More questions
No. Rybelsus is authorised in the EU for type 2 diabetes only. Oral semaglutide for weight management is authorised separately, under a different name and at different doses.

Other medicines used in weight management

Talk to a doctor about weight care

The Docalo membership gives you a doctor's assessment, a personalised plan and monthly follow-up. Your doctor decides what care suits you, with or without medicine.

Talk to a doctor about weight careGeneral information, not medical advice. Docalo does not sell medicines, and prescription-only medicines are prescribed only after an individual medical assessment.
All content on this page has been medically reviewed by: Dr. Alejandro Infante, General medicine, on 27 July 2026. Registration: 080869277

Pay nothing if a doctor doesn't approve your treatment. Every consultation is fully refundable. How refunds work